4:31pm ET
Health and Healthcare
Amgen Posts Handy Beat on Estimates and Guidance
Amgen reported better-than-expected fourth-quarter financial results after the markets closed Thursday.
Chris Lange AMGN Coverage Page 27
Chris Lange 8:35am ET
Health and Healthcare
Short Sellers Increase Bets in Major Biotechs
Short interest increased in most of these selected biotech stocks for the most recent settlement date.
11:45am ET
Health and Healthcare
Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs
Credit Suisse sees solid fundamentals, despite a harsh market landscape, for large-cap biotech firms. It initiated several top biotech stocks with an Outperform rating.
8:35am ET
Health and Healthcare
Short Interest Remains Mixed for Major Biotechs
The short interest data are out for the December 31 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
10:02am ET
Investing
10 Top 2016 Stock Picks From Goldman Sachs, Merrill Lynch and Other Key Analysts
Which well-known and large cap stocks to do the major analysts on Wall Street like for 2016? Here are 10.
8:35am ET
Investing
5 Top Goldman Sachs Stocks to Buy for 2016
Goldman Sachs has seen many top stocks offering great rewards for 2016. The reason may be different for each, but these are what the wealthiest and most sophisticated investors have been told…
8:40am ET
Health and Healthcare
Short Interest Remains Mixed in Major Biotechs
The short interest data are out for the December 15 settlement date, and short interest continued to be mixed in these selected biotech stocks.
12:15pm ET
Investing
4 High-Flying Stocks That Could Fly Even Higher in 2016
Here are four stocks that, while expensive at current levels, have fundamentals good enough to continue and even exceed their success in 2015 through next year.
7:10am ET
Health and Healthcare
4 Top Biotech Stocks for 2016
Biotech looks set to close out 2015 as its worst performing year since 2008. But can we expect a better 2016 for this exciting sector?
4:52pm ET
Health and Healthcare
How Amgen’s Larger-Than-Expected Dividend Hike Stacks Up to Peers
Amgen is getting aggressive enough on its dividend payout that you might think the biotech giant is now just a Big Pharma stock.
8:40am ET
Health and Healthcare
Mixed Views on Major Biotech Short Interest
The November 30 short interest data have been compared with the previous report, and short interest was mixed in these selected stocks for this settlement date.
9:06am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
24/7 Wall St. has reviewed the short interest data on the top biotech companies.
7:45am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The short interest data are out for the October 30 settlement date, and short interest fell in selected biotech stocks.
4:41pm ET
Health and Healthcare
Amgen Beats Earnings With Solid Outlook For 2015
ThinkstockAmgen Inc. (NASDAQ: AMGN) released its third quarter earnings report Wednesday after the markets closed. The biotech giant had $2.72 in earnings per share (EPS) on $5.72 billion in revenue compared to…
Chris Lange 11:25am ET
Health and Healthcare
What to Expect From Amgen Earnings
Amgen is scheduled to report its third-quarter financial results after the markets close on Wednesday.
Chris Lange